The first study (2023) evaluated 7,051 patients undergoing TKA who were prescribed semaglutide preoperatively, comparing them to a matched control group of 34,524 non-users
Boxed warning thyroid C-cell tumors: GLP-1-based medications (including semaglutide, tirzepatide, and orforglipron) carry an FDA boxed warning for thyroid C-cell tumors observed in rodent studies
Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss
These products can be effective, but taking too much may cause cramping or diarrhea
If you're experiencing persistent vomiting, signs of dehydration, or inability to maintain adequate oral intake, seek prompt medical review
injection 1 hour in the dark period of either 0.1% wt/vol BSA (vehicle) or the GLP-1RA exendin-4 (0.1, 1, or 2 g/kg body weight